Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT

Nuclear Medicine Communications

Volumn 32, Issue 12, 2011, Pages 1143-1147

  Rietbergen, Daphne D D ^a   Van Der Hiel, Bernies ^b   Vogel, Wouter ^a   Stokkel, Marcel P M ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; METHYL CHOLINE F 18; PROSTATE SPECIFIC ANTIGEN; TRACER; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RECURRENCE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG UPTAKE; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG INFECTION; LUNG METASTASIS; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PROSTATE BIOPSY; PROSTATE CARCINOMA; SMOKING;

AGED; CHOLINE; FLUORINE RADIOISOTOPES; HUMANS; LYMPH NODES; MALE; MEDIASTINUM; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS;

EID: 80455129632     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834b76fa     Document Type: Article

References (14)

1. Cremers RGHM, Karim-Kos HE, Houterman S, Verhoeven RHA, Schrö der FH, Van der Kwast TH, et al. Prostate cancer: trends in incidence, survival and mortality in the Netherlands, 1989-2006. Eur J Cancer 2010; 46:2077-2087.
2. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, et al. EAU guidelines on prostate cancer. Eur Urol 2008; 53:68-80.
3. Heinisch M, Dirisamer A, Loidl W, Stoiber F, Gruy B, Haim S, et al. Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA <5 ng/ml Mol. Imaging Biol. 2006 8 43-48
4. Picchio M, Briganti A, Fanti S, Heidenreich A, Krause B, Messa C, et al. The role of choline PET/CT in the management of patients with PSA progression after radical treatment of prostate cancer. Eur Urol 2011; 59:51-60.
5. Schillaci O, Calabria F, Tavolozza M, Ciccio C, Carlani M, Caracciolo CR, et al. 18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer. Nucl Med Commun 2010; 31:39-45.
6. Hara T, Kosaka N, Shinoura N, Kondo T. PET imaging of brain tumor with [methyl-C11]choline. J Nucl Med 1997; 38:842-847.
7. Hara T, Kosaka N, Kondo T, Kishi H, Kobori O. Imaging of brain tumor, lung cancer, esophagus cancer, colon cancer, prostate cancer, and bladder cancer with [C11]-choline. J Nucl Med 1997; 38:1058.
8. Hara T, Kosaka N, Kishi H. Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging. J Nucl Med 2002; 43:187-199.
9. Troost EG, Vogel WV, Merkx MA, Slootweg PJ, Marres HA, PeetersWJ, et al. 18 F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients. J Nucl Med 2007; 48:726-735.
10. Liu Q, Peng Z, Liu Q, Yao S, Zhang L, Meng L, et al. The role of 11C-choline positron emission tomography-computed tomography and videomediastinoscopy in the evaluation of diseases of middle mediastinum. Chin Med J 2006; 119:634-639.
11. Beheshti M, Imamovic L, Broinger G, Vali R, Waldenberger P, Stoiber F, et al. 18 F Choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. Radiology 2010; 254:925-933.
12. Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-Fluorocholine PET. J Nucl Med 2006; 47:262-269.
13. Picchio M, Crivellaro C, Giovacchini G, Gianolli L, Messa C. PET-CT for treatment planning in prostate cancer. Q J Nucl Med Mol Imaging 2009; 53:245-268.
14. Husarik D, Miralbell R, Dubs M, John H, Giger O, Gelet A, et al. Evaluation of 18-F-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging 2008; 35:253-263.